The mechanisms of action of three fluorine substituted cytosine analogs: implications for cancer chemotherapy.
D000970:Antineoplastic Agents / Q000494:pharmacology*; D001089:Arabinose / Q000494:pharmacology; D002478:Cells, Cultured; D003561:Cytarabine / Q000494:pharmacology; D003562:Cytidine / Q000031:analogs & derivatives / Q000494:pharmacology; D003596:Cytosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003857:Deoxyuridine / Q000378:metabolism; D005437:Flucytosine / Q000031:analogs & derivatives / Q000494:pharmacology; D005461:Fluorine / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009705:Nucleosides / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000970:Antineoplastic Agents; D009705:Nucleosides; D003561:Cytarabine; D014316:Tritium; D005461:Fluorine; D003562:Cytidine; D003596:Cytosine; D004247:DNA; D001089:Arabinose; D005437:Flucytosine; D013936:Thymidine; D003857:Deoxyuridine